{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-09T18:11:33.095219+00:00","published_at":"2026-10-09T04:48:32.027887+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1eev7ue1fej5ng","event_type":"CEO_CHANGED","effective_at":"2025-04-29","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:regina-m-graul-ph-d","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:360214bc2b6424c8de5c957846ff33a71491f59911ccba7256a5a1e95d3d92dd"],"summary":"Regina M. Graul, Ph.D. executive of Cyclerion Therapeutics, Inc., effective 2025-04-29.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1dkyf7m1fpuq4s","event_type":"CFO_CHANGED","effective_at":"2025-04-29","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:rhonda-m-chicko","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:0940532ae5fdfcd902fb3a2eb10fbfe6b63854af36ecf66fbe42dd77ebfaa31b"],"summary":"Rhonda M. Chicko executive of Cyclerion Therapeutics, Inc., effective 2025-04-29.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:16wit6fm1x3qp","event_type":"DIRECTOR_APPOINTED","effective_at":"2024-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:regina-m-graul-ph-d","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Regina M. Graul, Ph.D. seat on Cyclerion Therapeutics, Inc., effective 2024-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1maovr0aih316","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:dina-katabi-ph-d","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Dina Katabi, Ph.D. seat on Cyclerion Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bt3iqw1m7asyk","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:michael-f-higgins","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Michael F. Higgins seat on Cyclerion Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1iewdz41ufo52k","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:committee:cyclerion-therapeutics-inc:audit-chair-compensation","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Audit · Chair; Compensation committee of Cyclerion Therapeutics, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:7drph3vqokgn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:michael-f-higgins","alpha:committee:cyclerion-therapeutics-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Michael F. Higgins member of Audit · Chair; Compensation, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ro0x1z1mzawoz","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:steven-e-hyman-m-d","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Steven E. Hyman, M.D. seat on Cyclerion Therapeutics, Inc., effective 2022-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14yi17h1vhoj9f","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:errol-b-de-souza-ph-d","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Errol B. De Souza, Ph.D. seat on Cyclerion Therapeutics, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1lkkg441b27pwe","event_type":"DIRECTOR_APPOINTED","effective_at":"2019-01-01","detected_at":"2026-10-09T04:48:32.027887+00:00","subject_ids":["alpha:person:peter-m-hecht-ph-d","alpha:company:dc63c659-5918-479d-8f51-69ba8312563d"],"caused_claim_ids":["alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8"],"summary":"Peter M. Hecht, Ph.D. seat on Cyclerion Therapeutics, Inc., effective 2019-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:5","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:dina-katabi-ph-d","object_label":"Dina Katabi, Ph.D.","object_source_name_forms":[],"value":"Dina Katabi, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:dina-katabi-ph-d","name":"Dina Katabi, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cyclerion Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:01.917+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:6","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:errol-b-de-souza-ph-d","object_label":"Errol B. De Souza, Ph.D.","object_source_name_forms":[],"value":"Errol B. De Souza, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:errol-b-de-souza-ph-d","name":"Errol B. De Souza, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cyclerion Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:01.917+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:7","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:michael-f-higgins","object_label":"Michael F. Higgins","object_source_name_forms":[],"value":"Michael F. Higgins: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:michael-f-higgins","name":"Michael F. Higgins"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cyclerion Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:01.917+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:8","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:peter-m-hecht-ph-d","object_label":"Peter M. Hecht, Ph.D.","object_source_name_forms":[],"value":"Peter M. Hecht, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:peter-m-hecht-ph-d","name":"Peter M. Hecht, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cyclerion Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:01.917+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:9","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:regina-m-graul-ph-d","object_label":"Regina M. Graul, Ph.D.","object_source_name_forms":[],"value":"Regina M. Graul, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:regina-m-graul-ph-d","name":"Regina M. Graul, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cyclerion Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:01.917+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:10","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steven-e-hyman-m-d","object_label":"Steven E. Hyman, M.D.","object_source_name_forms":[],"value":"Steven E. Hyman, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steven-e-hyman-m-d","name":"Steven E. Hyman, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cyclerion Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:01.917+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:11","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:regina-m-graul-ph-d","object_label":"Regina M. Graul, Ph.D.","object_source_name_forms":[],"value":"Regina M. Graul, Ph.D.: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:regina-m-graul-ph-d","name":"Regina M. Graul, Ph.D."},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:360214bc2b6424c8de5c957846ff33a71491f59911ccba7256a5a1e95d3d92dd","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CYCN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-16T01:18:35.499772+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:dc63c659-5918-479d-8f51-69ba8312563d:leadership_role:12","subject_id":"alpha:company:dc63c659-5918-479d-8f51-69ba8312563d","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:rhonda-m-chicko","object_label":"Rhonda M. Chicko","object_source_name_forms":[],"value":"Rhonda M. Chicko: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:rhonda-m-chicko","name":"Rhonda M. Chicko"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2025-04-29","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-04-29","valid_to":null,"recorded_at":"2026-10-09T04:48:32.027887+00:00","sources":[{"id":"alpha:projection-evidence:document:0940532ae5fdfcd902fb3a2eb10fbfe6b63854af36ecf66fbe42dd77ebfaa31b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CYCN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-16T01:18:36.069668+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29T00:00:00+00:00","effective_from":"2025-04-29","effective_until":null,"observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:35ef1157fdd56119cd2b36a0b0aa99014d68e54fcca8014df96f5410bb60aaf8","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Cyclerion Therapeutics, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:01.917+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:360214bc2b6424c8de5c957846ff33a71491f59911ccba7256a5a1e95d3d92dd","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CYCN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-16T01:18:35.499772+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0940532ae5fdfcd902fb3a2eb10fbfe6b63854af36ecf66fbe42dd77ebfaa31b","identity_scope":"source_document_reference","source_type":"sec_filing","title":"CYCN DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1755237/000114036125016370/ny20045439x1_def14a.htm","source_date":"2025-04-29T00:00:00+00:00","retrieved_at":"2026-05-16T01:18:36.069668+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.841,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.838,"cross_source_agreement":0.75,"temporal_completeness":0.8},"diagnostics":{"published_claims":16,"factual_claims":16,"claims_with_linked_evidence":16,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":10,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-09T04:48:32.027887+00:00","observed_at":"2026-10-09T04:48:32.027887+00:00","reviewed_at":"2026-10-09T04:48:32.027887+00:00","verified_at":"2026-10-09T04:48:32.027887+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":16,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/cyclerion-therapeutics-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/cyclerion-therapeutics-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}